Scott Button joined Venture Investors in 1996 as a Senior Associate, and became a Managing Director of Venture Investors in 2000. Scott focuses on investments in medical devices, digital health,
Scott Button joined Venture Investors in 1996 as a Senior Associate, and became a Managing Director of Venture Investors in 2000. Scott focuses on investments in medical devices, digital health, technology enabled services, and diagnostics, and is responsible for creating and overseeing Venture Investor’s seed investment strategy through the firm’s Venture Igniter Program.
Scott has over fifteen years of portfolio company board experience, including his current directorships at Silatronix, Elucent Medical (founded by NeuWave Medical founders), and HealthMyne (founded by a Tomotherapy founder). He is also a Board Observer at Thalchemy. He uses his network and extensive experience to identify novel technologies on campus that have the potential to turn into start-ups. Silatronix is a Venture Igniter company where the firm took a founding role in its formation. Scott led the original round of financing for NeuWave Medical when the company was comprised of one employee and the four founders. He was instrumental in identifying and recruiting its CEO and second employee at the time of our original investment. NeuWave was acquired by Johnson & Johnson’s Ethicon division and was single largest return to any Venture Investors fund.
Prior to joining Venture Investors, Scott worked for McDonald’s Corporation as an operations manager, and for Rockwell Automation as a field sales engineer in the automotive industry.
BioPathways is a monthly event series, featuring prominent bioentrepreneurs, biotech executives and biotech investors in a fireside chat.
(Tuesday) 4:30 PM - 5:30 PM Central Time